FDA Targets Executives With Powerful Misdemeanor Strategy
This article was originally published in The Tan Sheet
Executive Summary
Executives could face virtually unbeatable government criminal prosecutions and prison sentences more frequently if FDA follows recently announced enforcement plans, industry attorneys warn
You may also be interested in...
FDA Expects STD Claims Enforcement To Deter Future Violations
FDA will consider prosecuting executives of firms making unapproved sexually transmitted disease treatment claims for OTC drugs and nutritional products, the targets of its latest enforcement sweep.
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements
FDA threatens to take "swift and strong" enforcement action without warning, including filing criminal charges, against manufacturers, suppliers and distributors of tainted supplements, according to a letter sent to industry Dec. 15.